MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)
Clinical trial NCT05335005 · COMPLETED
Trial details
- NCT number
- NCT05335005
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2023-02-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.